Please assess the completion status of the following clinical trial:

Trial Title: Ease of Use of New Blood Glucose Meter With In-built Insulin Calculator at Home Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subject with Type 1 or 2 diabetes on a bolus regime (U100 insulin), one or more bolus injections per day for at least 6 months;~* Age 18 yrs and above;~* Regularly testing SMBG 3 or more times per day;~* Willingness to test at least 4 times per day.~Exclusion Criteria:~* Know to require a bolus injection of more than 50U in a single dose;~* Has previously used either the InsuLinx or assigned comparison meter;~* Participated in structured diabetes management training in the last 6 months~* Is currently on an insulin pump;~* Has concomitant disease that, in the Investigator's opinion, may compromise patient safety;~* Is participating in another study of a glucose monitoring device or drug that could affect glucose measurements or glucose management;~* Female subject who is pregnant or planning to become pregnant during the course of the study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- ADC, Then Comparator, Then ADC With Calculator (Type: EXPERIMENTAL): Subject used the ADC blood glucose meter for 7 days with the insulin calculator not activated, followed by a comparator blood glucose meter for 7 days. For the last 10 days the subject used the ADC blood glucose meter with insulin calculator active.
- Comparator, Then ADC, Then ADC With Calculator (Type: EXPERIMENTAL): Subject used a comparator blood glucose meter for 7 days, followed by the ADC blood glucose meter for 7 days, with the insulin calculator not activated. For the last 10 days the subject used the ADC blood glucose meter with insulin calculator active.

Based on this trial design, predict the completion outcome and termination type (if applicable).